Delivery Order SPE2DB22D2108-SPE2DB25FU5EF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.54 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (8 grams) with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.11 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside contract utilized firm fixed pricing and was performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $13,669.86 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhaler 12gm on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $3,068.76 to AmerisourceBergen Drug Corp for Advair HFA 45-21 microgram inhalers (12 grams) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,483.95 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 grams). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and was awarded on July 25, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.34 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on August 1, 2025, with a completion date of August 4, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5EFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,592.35 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities through competitively awarded contracts with firm fixed pricing structures. The Advair HFA inhaler delivery supports the DLA Medical Supply Chain's ongoing pharmaceutical requirements for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 7/22/25 |